文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells.

作者信息

Maji Moumita, Bhattacharya Indira, Acharya Sourav, Chakraborty Manas Pratim, Gupta Arnab, Mukherjee Arindam

机构信息

Department of Chemical Sciences and Centre for Advanced Functional Materials, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur 741246, West Bengal, India.

Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur 741246, West Bengal, India.

出版信息

Inorg Chem. 2021 Apr 5;60(7):4342-4346. doi: 10.1021/acs.inorgchem.0c03803. Epub 2021 Mar 12.


DOI:10.1021/acs.inorgchem.0c03803
PMID:33711231
Abstract

Platinum(IV) complexes of orotic acid selectively target liver cancer cells displaying enhanced activity and higher uptake in Hep G2. The comparatively higher expression of Organic Anion Transporter 2 (OAT2) in Hep G2 and decrease in toxicity in the presence of OAT2 inhibitor suggest its involvement in the uptake of the complexes. They are resistant to sequestration by the copper transporter ATP7B, unlike cisplatin and oxaliplatin.

摘要

相似文献

[1]
Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells.

Inorg Chem. 2021-4-5

[2]
Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.

Chem Commun (Camb). 2018-1-18

[3]
A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.

Chem Commun (Camb). 2012-11-11

[4]
Novel hypoxia-targeting Pt(iv) prodrugs.

Chem Commun (Camb). 2017-3-28

[5]
Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent Pt Anticancer Prodrug.

Angew Chem Int Ed Engl. 2018-6-14

[6]
Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs.

Dalton Trans. 2024-9-10

[7]
Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.

Eur J Med Chem. 2018-8-27

[8]
Nitric oxide-releasing platinum(IV) prodrug efficiently inhibits proliferation and metastasis of cancer cells.

Chem Commun (Camb). 2020-11-12

[9]
Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?

J Med Chem. 2021-8-12

[10]
Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.

Dalton Trans. 2020-1-16

引用本文的文献

[1]
Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Cancer Cells.

J Am Chem Soc. 2023-6-21

[2]
Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer patients: current perspectives and future directions.

Med Oncol. 2023-1-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索